eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Stephen T. Worland,PhD$6.6M
Market Cap • 18/04/20242020
(há 4 anos)
2021
(3 years ago)
NASDAQ
Listagem
Solana Beach
Sede • California15
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
EFTRSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.